HK1174555A1 - 含維生素 和二甲雙胍的藥物組合物 - Google Patents

含維生素 和二甲雙胍的藥物組合物

Info

Publication number
HK1174555A1
HK1174555A1 HK13101819.2A HK13101819A HK1174555A1 HK 1174555 A1 HK1174555 A1 HK 1174555A1 HK 13101819 A HK13101819 A HK 13101819A HK 1174555 A1 HK1174555 A1 HK 1174555A1
Authority
HK
Hong Kong
Prior art keywords
metformin
composition containing
medicine composition
containing vitamin
vitamin
Prior art date
Application number
HK13101819.2A
Other languages
English (en)
Inventor
范富林
余劍橋
梁健儀
Original Assignee
廣東泰禾醫藥科技有限公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 廣東泰禾醫藥科技有限公司 filed Critical 廣東泰禾醫藥科技有限公司
Publication of HK1174555A1 publication Critical patent/HK1174555A1/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A61K31/592—9,10-Secoergostane derivatives, e.g. ergocalciferol, i.e. vitamin D2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A61K31/593—9,10-Secocholestane derivatives, e.g. cholecalciferol, i.e. vitamin D3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
HK13101819.2A 2011-02-11 2013-02-08 含維生素 和二甲雙胍的藥物組合物 HK1174555A1 (zh)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201110036080.2A CN102631354B (zh) 2011-02-11 2011-02-11 含维生素d3和二甲双胍的药物组合物

Publications (1)

Publication Number Publication Date
HK1174555A1 true HK1174555A1 (zh) 2013-06-14

Family

ID=46616035

Family Applications (1)

Application Number Title Priority Date Filing Date
HK13101819.2A HK1174555A1 (zh) 2011-02-11 2013-02-08 含維生素 和二甲雙胍的藥物組合物

Country Status (6)

Country Link
US (1) US9333210B2 (zh)
JP (1) JP5792322B2 (zh)
CN (1) CN102631354B (zh)
GB (1) GB2502232B (zh)
HK (1) HK1174555A1 (zh)
WO (1) WO2012106947A1 (zh)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9622982B2 (en) 2013-01-14 2017-04-18 Health Clinics Limited Cancer drug and uses
CN104644649A (zh) * 2013-11-21 2015-05-27 广东泰禾医药科技有限公司 抑制igf-1信号转导通路的药物组合物
WO2016062278A1 (zh) * 2014-10-24 2016-04-28 朗齐生物医学股份有限公司 内分泌疾病用药在制备抑制癌症的医药组合物中的应用

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002302447A (ja) * 2001-04-03 2002-10-18 Shimizu Pharmaceutical Co Ltd 局所投与用癌治療剤
US6831102B2 (en) * 2001-12-07 2004-12-14 Bristol-Myers Squibb Company Phenyl naphthol ligands for thyroid hormone receptor
US20050054731A1 (en) * 2003-09-08 2005-03-10 Franco Folli Multi-system therapy for diabetes, the metabolic syndrome and obesity
TW200524595A (en) * 2003-10-06 2005-08-01 Bristol Myers Squibb Co Methods for treating IGF1R-inhibitor induced hyperglycemia
US7704980B2 (en) * 2003-10-08 2010-04-27 Wisconsin Alumni Research Foundation Treatment of inflammatory bowel disease with 2-methylene-19-nor-vitamin D compounds
JP2009508847A (ja) * 2005-09-16 2009-03-05 イッサム リサーチ ディヴェロップメント カンパニー オブ ザ ヘブリュー ユニバーシティー オブ エルサレム 栄養状態、認知および生存を改善するための化合物
US20090163452A1 (en) * 2007-12-20 2009-06-25 Schwartz Janice B Compositions and methods for lowering serum cholesterol
WO2011149337A1 (en) * 2010-05-28 2011-12-01 Bethesda Diabetes Research Centrum B.V. New combination treatment for type 2 diabetes and other disorders related to insulin resistance
WO2012122295A2 (en) * 2011-03-07 2012-09-13 Ned Biosystems, Inc. Treatment for pancreatic adenocarcinoma and other cancers of epithelial origin

Also Published As

Publication number Publication date
CN102631354B (zh) 2015-01-21
JP2014505079A (ja) 2014-02-27
US9333210B2 (en) 2016-05-10
GB2502232A (en) 2013-11-20
JP5792322B2 (ja) 2015-10-07
US20140031322A1 (en) 2014-01-30
CN102631354A (zh) 2012-08-15
GB201315721D0 (en) 2013-10-16
GB2502232B (en) 2018-10-03
WO2012106947A1 (zh) 2012-08-16

Similar Documents

Publication Publication Date Title
HRP20181433T1 (hr) Farmaceutski pripravak koji sadrži mio-inozitol i d-chiro-inozitol
AP3864A (en) Pharmaceutical composition
HK1214170A1 (zh) 含有瑞戈非尼的包衣的藥物組合物
GB2502032B (en) Stable Vitamin D3 Composition
GB201118232D0 (en) Pharmaceutical composition
HK1189158A1 (zh) 藥用組合物
GB201111630D0 (en) Novel compounds and their use
EP2769718A4 (en) MEDICINAL COMPOSITION
HK1174555A1 (zh) 含維生素 和二甲雙胍的藥物組合物
EP2727593A4 (en) PHARMACEUTICAL COMPOSITION CONTAINING NICORANDIL
PT2638894T (pt) Composição farmacêutica com fosfolípido
EP2774617A4 (en) MEDICAL COMPOSITION USING EXTRACT OF STAUNTONIA HEXAPHYLLA
EP2711010A4 (en) PHARMACEUTICAL COMPOSITION
HUP1100444A2 (en) Pharmaceutical composition
EP2883546A4 (en) NOVEL DIFFERENTIALLY RELEASING PHARMACEUTICAL COMPOSITION CONTAINING THREE ACTIVE INGREDIENTS
HUP1100445A2 (en) Pharmaceutical composition
ZA201309537B (en) Pharmaceutical composition comprising fexofedine
GB201108393D0 (en) Vitamin D composition
GB201104875D0 (en) New compounds and medical uses
GB201104872D0 (en) New compounds and medical uses

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20220211